{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T21:48:45Z","timestamp":1696369725882},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2166,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/ki.2009.349","type":"journal-article","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T09:05:10Z","timestamp":1256115910000},"page":"88-92","source":"Crossref","is-referenced-by-count":7,"title":["Linking an insect enzyme to hypertension: angiotensin II\u2013epoxide hydrolase interactions"],"prefix":"10.1016","volume":"77","author":[{"given":"Ding","family":"Ai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Y.-J.","family":"Shyy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2009.349_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2004.10.001","article-title":"Epoxide hydrolases: their roles and interactions with lipid metabolism","volume":"44","author":"Newman","year":"2005","journal-title":"Prog Lipid Res"},{"key":"10.1038\/ki.2009.349_bb0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(93)90805-R","article-title":"Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid","volume":"230","author":"Hu","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1038\/ki.2009.349_bb0020","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1038\/ki.2009.349_bb0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2009.349_bb0030","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids","volume":"87","author":"Yu","year":"2000","journal-title":"Circ Res"},{"key":"10.1038\/ki.2009.349_bb0035","first-page":"1244","article-title":"Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage","volume":"15","author":"Zhao","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.349_bb0040","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/hy0202.103788","article-title":"Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension","volume":"39","author":"Imig","year":"2002","journal-title":"Hypertension"},{"key":"10.1038\/ki.2009.349_bb0045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/01.HYP.0000153792.29478.1d","article-title":"Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension","volume":"45","author":"Jung","year":"2005","journal-title":"Hypertension"},{"key":"10.1038\/ki.2009.349_bb0050","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.HYP.0000176237.74820.75","article-title":"An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension","volume":"46","author":"Imig","year":"2005","journal-title":"Hypertension"},{"key":"10.1038\/ki.2009.349_bb0055","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/jpet.103.052787","article-title":"Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways","volume":"307","author":"Wang","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/ki.2009.349_bb0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/ATVBAHA.108.171298","article-title":"Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice","volume":"29","author":"Hercule","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/ki.2009.349_bb0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/CS20080039","article-title":"Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats","volume":"116","author":"Olearczyk","year":"2009","journal-title":"Clin Sci (London)"},{"key":"10.1038\/ki.2009.349_bb0070","doi-asserted-by":"crossref","first-page":"9018","DOI":"10.1073\/pnas.0703229104","article-title":"Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo","volume":"104","author":"Ai","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2009.349_bb0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"Monti","year":"2008","journal-title":"Nat Genet"},{"key":"10.1038\/ki.2009.349_bb0080","doi-asserted-by":"crossref","first-page":"16747","DOI":"10.1073\/pnas.0508081102","article-title":"The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase","volume":"102","author":"Liu","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2009.349_bb0085","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/01.CIR.0000139850.08365.EC","article-title":"Laminar flow activates peroxisome proliferator-activated receptor-gamma in vascular endothelial cells","volume":"110","author":"Liu","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/ki.2009.349_bb0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/FJC.0b013e318185fa3c","article-title":"Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model","volume":"52","author":"Ulu","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1038\/ki.2009.349_bb0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FJC.0b013e3181506445","article-title":"The soluble epoxide hydrolase as a pharmaceutical target for hypertension","volume":"50","author":"Chiamvimonvat","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1038\/ki.2009.349_bb0100","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2009.349_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yjmcc.2008.09.711","article-title":"Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model","volume":"46","author":"Batchu","year":"2009","journal-title":"J Mol Cell Cardiol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815542026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815542026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:48:36Z","timestamp":1558586916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815542026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0085253815542026"],"URL":"https:\/\/doi.org\/10.1038\/ki.2009.349","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}